Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C2352
http://purl.obolibrary.org/obo/NCIT_C2352
|
|---|---|
| Preferred Name | Methylmercaptopurine Riboside |
| Definitions |
A purine derivative with antineoplastic and anti-angiogenic properties. 6-methylmercaptopurine riboside (6-MMPR) inhibits amidophosphoribosyltransferase, the first committed step in de novo purine synthesis, and inhibits fibroblast growth factor-2 (FGF2)-induced cell proliferation. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A purine derivative with antineoplastic and anti-angiogenic properties. 6-methylmercaptopurine riboside (6-MMPR) inhibits amidophosphoribosyltransferase, the first committed step in de novo purine synthesis, and inhibits fibroblast growth factor-2 (FGF2)-induced cell proliferation. (NCI04) |
|---|---|
| label | Methylmercaptopurine Riboside
|
| prefLabel | Methylmercaptopurine Riboside
|
| Legacy Concept Name | Methylmercaptopurine_Riboside
|
| in_subset | |
| Preferred_Name | Methylmercaptopurine Riboside
|
| Is_Value_For_GDC_Property | |
| Maps_To | Methylmercaptopurine Riboside
|
| PDQ_Open_Trial_Search_ID | 39497
|
| UMLS_CUI | C0025828
|
| FDA_UNII_Code | Y5G39SHR0V
|
| prefixIRI | NCIT:C2352
|
| NCI_Drug_Dictionary_ID | 39497
|
| Contributing_Source | FDA
|
| subClassOf | |
| code | C2352
|
| type | |
| NSC Number | 40774
|
| PDQ_Closed_Trial_Search_ID | 39497
|
| Semantic_Type |
Pharmacologic Substance
Nucleic Acid, Nucleoside, or Nucleotide
|
| CAS_Registry | 342-69-8
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |